🔓
Sign in as a Member to unlock the full view of CYTK. · Full hedge fund list, every line-item carveout, cabinet conflicts, and politicians-trading detail.
Become a Member$29.99/mo already a Member? Sign in →
CYTK

Cytokinetics, Incorporated

Sector: healthcareBiotechnologyNASDAQMarket Cap: $8.31B

Cytokinetics is a clinical-stage biopharmaceutical company developing cardiac and skeletal muscle activators with minimal direct government dependence but significant FDA regulatory exposure.

Next filing → your inbox
Govt Dependence
15/100
Regulatory Density
85/100
Lobbying Intensity
5/100
Political Signal
LOW

BusinessWhat CYTK does

Cytokinetics discovers and develops small-molecule therapeutics targeting cardiac and skeletal muscle function, primarily for heart failure and neuromuscular diseases. The company is pre-commercial or early-commercial, with revenue dependent on clinical trial progression, regulatory approvals, and eventual commercialization partnerships or licensing deals.

12 months past · 3 months futureCYTK activity timeline

$90$71$52 DecJan '26FebMarAprMayJunJulAugSepOctNovDecJan '27Feb ↓ PAST — recorded activity ↑ FUTURE — scheduled markups · pending votes TODAY · Nov 17 $87.26 hi $53.17 lo $53.17 CONGRESS 8 INSIDERS 0 13F FUNDS 30 BILLS 30 Gilbert Ray Cisneros (D) · Purchase · 2026-09-29Gilbert Ray Cisneros (D) · Purchase · 2026-06-30 Citadel Advisors · + $168M · 2026-06-30Point72 Asset Management · + $135M · 2026-06-30Citadel Advisors · + $102M · 2026-03-31D.E. Shaw & Co. · + $89M · 2026-06-30D.E. Shaw & Co. · + $49M · 2026-03-31Citadel Advisors · - $47M · 2025-12-31Point72 Asset Management · OPENED $44M · 2026-03-31Two Sigma Investments · + $27M · 2026-06-30Two Sigma Investments · + $27M · 2026-06-30Millennium Management · + $22M · 2026-03-31Two Sigma Investments · + $20M · 2026-03-31Two Sigma Investments · - $19M · 2026-03-31Millennium Management · - $18M · 2026-06-30Two Sigma Investments · - $17M · 2025-12-31 HR.41 · passed_one · 2026-06-03HR.184 · reported · 2026-09-15HR.178 · reported · 2026-01-08HR.109 · committee · 2025-12-19 MARKUP · Senate Veterans' Affairs · 2026-11-18MARKUP · Senate Finance · 2026-11-18MARKUP · Senate Health, Education, Labor, and Pensions · 2026-11-18MARKUP · Senate Budget · 2026-11-18MARKUP · Senate Veterans' Affairs · 2026-11-18
Congress
buy sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened + added − trimmed closed holds
Bills
past action (this ticker) upcoming markup (sector) ★ carveout (this ticker)
250 trading days · 2 congressional trades shown · 0 insider buys · 14 13F filings · 4 past bill actions · 5 upcoming markups

Lifetime Government AwardsCYTK federal contracts

CYTK doesn't hold direct federal contracts.

Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.

Smart Money · 13F HoldingsHedge funds holding CYTK

$477.6M
Total CYTK held by tracked 13F funds
7
Funds with CYTK positions
Citadel Advisors $168M +27% 1 overlap 2026-06-30
Point72 Asset Management $135M +140% 1 overlap 2026-06-30
D.E. Shaw & Co. $89M +40% 1 overlap 2026-06-30
Two Sigma Investments $27M +11% 1 overlap 2026-06-30
Two Sigma Investments $27M +4868% 1 overlap 2026-06-30
Millennium Management $18M -36% 1 overlap 2026-06-30
AQR Capital Management $14M holds 1 overlap 2026-06-30

Politicians Trading CYTKMembers of Congress with recent CYTK positions

2 politicians traded CYTK across 8 disclosed transactions totaling $64K (last 730 days). Greed score = composite of trade frequency, volume & recency across the politician's entire history (not just CYTK). 0-30 LOW · 30-60 MID · 60+ HIGH.

Congressional TradesWho in Congress is trading CYTK

2026-09-29 Gilbert Ray Cisneros D-California · house Purchase $1,001 - $15,000
2026-06-30 Gilbert Ray Cisneros D-California · house Purchase $1,001 - $15,000
2025-10-09 Gilbert Ray Cisneros D-California · house purchase $1,001 - $15,000
2025-10-09 Gilbert Ray Cisneros D-California · house Purchase $1,001 - $15,000
2025-06-11 Lisa C. McClain R-Michigan · house purchase $1,001 - $15,000 63d late
2025-06-17 Lisa C. McClain R-Michigan · house sale $1,001 - $15,000 57d late
2025-06-11 Lisa C. McClain R-Michigan · house Purchase $1,001 - $15,000 63d late
2025-06-17 Lisa C. McClain R-Michigan · house Sale $1,001 - $15,000 57d late
8+ trades on file · most recent 2026-10-12

Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock

Stock awards & option exercises

12
stock awards · $145K market value
32
option exercises · $3.8M
2026-10-16 HENDERSON JOHN T Director AWARD 352 sh $23K
2026-10-16 Daly James M Director AWARD 195 sh $12K
2026-10-16 Harrington Robert Arthur Director AWARD 195 sh $12K
2026-10-16 Kaye Edward M. MD Director AWARD 195 sh $12K
2026-10-16 Wysenski Nancy Director AWARD 97 sh $6K
2026-10-16 WIERENGA WENDELL Director AWARD 97 sh $6K
2026-07-15 HENDERSON JOHN T Director AWARD 272 sh $22K
2026-07-15 Daly James M Director AWARD 151 sh $12K
For CYTK, executives receive stock primarily as compensation rather than via open-market purchases — typical for established large-cap firms.

Bills Affecting CYTKLive legislation impacting this stock

Political ProfileWhere CYTK sits in Washington

Clinical-stage biotech stocks are driven primarily by clinical trial results, FDA decisions, and capital markets rather than legislative/regulatory news. Politician trades appear incidental rather than signal-driven.

Regulatory ExposureThreats & opportunities

Regulatory threats

  • FDA clinical trial delays
  • Medicare pricing pressure on future commercialized products
  • patent litigation

Regulatory opportunities

  • Breakthrough Therapy designation
  • Accelerated Approval pathway
  • NIH grant funding
Member intelligence layer

Live signals + predictions for CYTK — for Founders

The free page above gives you the public record. Members see the real-time intelligence layer on top of it:

Become a Founder · $29.99/mo Locked rate forever · cancel anytime

Frequently AskedAbout CYTK & political exposure

Does Cytokinetics, Incorporated (CYTK) hold federal contracts?
No direct prime contracts reported in USASpending.gov for Cytokinetics, Incorporated. Companies in the semiconductor and AI hardware sectors often sell to the federal government via prime contractors and cloud resellers (Microsoft Azure, AWS, Lockheed Martin systems integration) rather than as direct primes.
Has Congress traded CYTK stock?
8 congressional trades by 2 unique members of Congress, most recently on 2026-09-29. See the Congressional Trading panel for politician-by-politician breakdown.
What is CYTK political risk profile?
Government dependence: 15/100. Lobbying intensity: 5/100. Political signal: low.
How does GovGreed track CYTK political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. CYTK data is updated daily from these official federal sources.